MicroRNA-1207-5p inhibits hepatocellular carcinoma cell growth and invasion through the fatty acid synthase-mediated Akt/mTOR signalling pathway.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Oncology Report

• Publication date

  2016-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/or.2016.4952PMID 27461404
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNAs Provide Feedback Regulation of Epithelial‐Mesenchymal Transition Induced by Growth Factors

  2016cited by this paper
• Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans.

  2016cited by this paper
• Downregulation of fatty acid synthase complex suppresses cell migration by targeting phosphor-AKT in bladder cancer.

  2016cited by this paper
• Long noncoding RNA BC032469, a novel competing endogenous RNA, upregulates hTERT expression by sponging miR-1207-5p and promotes proliferation in gastric cancer

  2016cited by this paper
• Loss of fatty acid synthase suppresses the malignant phenotype of colorectal cancer cells by down-regulating energy metabolism and mTOR signaling pathway

  2015cited by this paper
• Molecular Pathways: Fatty Acid Synthase

  2015cited by this paper
• MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

  2015cited by this paper
• Cancer statistics, 2015

  2015cited by this paper
• miRNA–mRNA Interaction Network in Non-small Cell Lung Cancer

  2015cited by this paper
• Effects of Ganoderma lucidum (Higher Basidiomycetes) Extracts on the miRNA Profile and Telomerase Activity of the MCF-7 Breast Cancer Cell Line.

  2015cited by this paper
• Emerging role of microRNAs in lipid metabolism

  2015cited by this paper
• Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells

  2015cited by this paper
• The Correlation between miRNA and Lymph Node Metastasis in Gastric Cancer

  2015cited by this paper
• CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways.

  2015cited by this paper
• Tubeimoside-1 suppresses tumor angiogenesis by stimulation of proteasomal VEGFR2 and Tie2 degradation in a non-small cell lung cancer xenograft model

  2015cited by this paper
• MicroRNA biogenesis pathways in cancer

  2015cited by this paper
• The role of circulating microRNA in hepatocellular carcinoma.

  2015cited by this paper
• Diacylglycerol Metabolism and Signaling Is a Driving Force Underlying FASN Inhibitor Sensitivity in Cancer Cells.

  2015cited by this paper
• MicroRNAs in cancer: biomarkers, functions and therapy.

  2014cited by this paper
• RETRACTED ARTICLE: MicroRNA-320 inhibits osteosarcoma cells proliferation by directly targeting fatty acid synthase

  2014cited by this paper
• Expression and roles of fatty acid synthase in hepatocellular carcinoma.

  2014cited by this paper
• RETRACTED ARTICLE: MicroRNA-142-3p, a novel target of tumor suppressor menin, inhibits osteosarcoma cell proliferation by down-regulation of FASN

  2014cited by this paper
• MicroRNA-449 suppresses proliferation of hepatoma cell lines through blockade lipid metabolic pathway related to SIRT1.

  2014cited by this paper
• Positive feedback regulation between Akt phosphorylation and fatty acid synthase expression in osteosarcoma.

  2014cited by this paper
• Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer

  2014cited by this paper
• miR-107 orchestrates ER stress induction and lipid accumulation by post-transcriptional regulation of fatty acid synthase in hepatocytes.

  2014cited by this paper
• Metformin-Induced Killing of Triple-Negative Breast Cancer Cells Is Mediated by Reduction in Fatty Acid Synthase via miRNA-193b

  2014cited by this paper
• microRNA: A Promising Diagnostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma

  2014cited by this paper
• Fatty acid synthase (FASN) levels in serum of colorectal cancer patients: correlation with clinical outcomes

  2014cited by this paper
• A human fatty acid synthase inhibitor binds β-ketoacyl reductase in the keto-substrate site.

  2014cited by this paper
• miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase

  2014cited by this paper
• Multidisciplinary treatments for hepatocellular carcinoma with major portal vein tumor thrombus

  2013cited by this paper
• Lipid metabolism in cancer.

  2013cited by this paper
• Inhibition of fatty acid synthase suppresses U-2 OS cell invasion and migration via downregulating the activity of HER2/PI3K/AKT signaling pathway in vitro.

  2013cited by this paper
• Inherent and Acquired Resistance to Paclitaxel in Hepatocellular Carcinoma: Molecular Events Involved

  2013cited by this paper
• Combined Phosphatase and Tensin Homolog (PTEN) Loss and Fatty Acid Synthase (FAS) Overexpression Worsens the Prognosis of Chinese Patients with Hepatocellular Carcinoma

  2012cited by this paper
• Lipid metabolism in cancer

  2012cited by this paper
• PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis.

  2011cited by this paper
• Association of lipid metabolism with ovarian cancer.

  2010cited by this paper
• Fatty acid synthase as a potential therapeutic target in cancer.

  2010cited by this paper
• Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: molecular mechanisms and therapeutic perspectives.

  2010cited by this paper
• Serum Fatty Acid Synthase as a Marker of Pancreatic Neoplasia

  2009cited by this paper
• Many roads to maturity: microRNA biogenesis pathways and their regulation

  2009cited by this paper
• EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells.

  2009cited by this paper
• Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells

  2008cited by this paper
• Co-expression of fatty acid synthase and caveolin-1 in pancreatic ductal adenocarcinoma: Implications for tumor progression and clinical outcome

  2008cited by this paper
• Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of β-catenin in prostate cancer

  2008cited by this paper
• "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis.

  2005cited by this paper
• Intensified Cloning Efforts Have Revealed Numer

  2004cited by this paper
• Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.

  2003cited by this paper
• Fatty acid synthesis: a potential selective target for antineoplastic therapy.

  1994cited by this paper

• NVP-2, in combination with Orlistat, represents a promising therapeutic strategy for acute myeloid leukemia

  2025cites this paper
• MicroRNA-Mediated Metabolic Control in HCC: From Molecular Networks to Therapy.

  2025cites this paper
• Lipid metabolism in cancer is regulated by the integrated natural product-miRNA-target axis.

  2025cites this paper
• Developing Potent Therapeutics for Liver Cancer Chemoresistance via an RNA Nanotech and Series-Circuit-Christmas-Bulb Mechanism Targeting ABC Transporters.

  2025cites this paper
• VDR Decrease Enhances the Efficacy of 1,25-Dihydroxyvitamin D3 Inhibiting Gefitinib Resistance by Regulating EGFR/FASN Loop in NSCLC Cells

  2025cites this paper
• Alterations in serum exosomal miR-1207-5p levels reflect severity and progression risk in type 2 diabetic kidney disease

  2025cites this paper
• Tristetraprolin Family Members and Processing Bodies: A Complex Regulatory Network Involved in Fatty Liver Disease, Viral Hepatitis and Hepatocellular Carcinoma

  2025cites this paper
• Bioinformatics-based analysis of fatty acid metabolic reprogramming in hepatocellular carcinoma: cellular heterogeneity, therapeutic targets, and drug discovery

  2024cites this paper
• Flavonoids attenuate cancer metabolism by modulating Lipid metabolism, amino acids, ketone bodies and redox state mediated by Nrf2.

  2023cites this paper
• Fatty acid synthase (FASN) signalome: A molecular guide for precision oncology

  2023cites this paper
• Therapeutically targeting essential metabolites to improve immunometabolism manipulation after liver transplantation for hepatocellular carcinoma

  2023cites this paper
• ncRNA-mediated fatty acid metabolism reprogramming in HCC.

  2023cites this paper
• A novel regulatory facet for hypertriglyceridemia: The role of microRNAs in the regulation of triglyceride-rich lipoprotein biosynthesis.

  2022cites this paper
• The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma

  2022cites this paper
• Epigenetic Regulation of Hepatocellular Carcinoma Progression through the mTOR Signaling Pathway

  2021cites this paper
• miR-1207-5p suppresses laryngeal squamous cell carcinoma progression by downregulating SKA3 and inhibiting epithelial-mesenchymal transition

  2021cites this paper
• Emergence of miRNAs as Key Players in Cancer Cell Metabolism

  2021cites this paper
• LncRNA MIR194-2HG Promotes Cell Proliferation and Metastasis via Regulation of miR-1207-5p/TCF19/Wnt/β-Catenin Signaling in Liver Cancer

  2020cites this paper
• Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A review

  2020cites this paper
• OTT_A_264614 9887..9899

  2020cites this paper
• LncRNA OR3A4 Regulated the Growth of Osteosarcoma Cells by Modulating the miR-1207-5p/G6PD Signaling

  2020cites this paper
• LncRNA OR3A4 Regulated the Growth of Osteosarcoma Cells by Modulating the miR-1207-5p/G6PD Signaling

  2020cites this paper
• Non-Coding and Regulatory RNAs as Epigenetic Remodelers of Fatty Acid Homeostasis in Cancer

  2020cites this paper
• Emergence of MicroRNAs as Key Players in Cancer Cell Metabolism.

  2019cites this paper
• Fenofibrate induces human hepatoma Hep3B cells apoptosis and necroptosis through inhibition of thioesterase domain of fatty acid synthase

  2019cites this paper
• Serum miRNA Are Promising Biomarkers for the Detection of Early Hepatocellular Carcinoma after Treatment with Direct-Acting Antivirals

  2019cites this paper
• Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma

  2019cites this paper
• Non-coding RNAs derailed: The many influences on the fatty acid reprogramming of cancer.

  2019cites this paper
• MicroRNA-129-5p suppresses cell proliferation, migration and invasion via targeting ROCK1 in osteosarcoma.

  2018cites this paper
• MicroRNA ‐ 129 ‐ 5 p suppresses cell proliferation , migration and invasion via targeting ROCK 1 in osteosarcoma

  2018cites this paper
• miR-21 promotes EGF-induced pancreatic cancer cell proliferation by targeting Spry2

  2018cites this paper
• The Role of MicroRNAs in Hepatocellular Carcinoma

  2018cites this paper
• mTOR signaling-related MicroRNAs and Cancer involvement

  2018cites this paper
• Upregulation of LINC00319 indicates a poor prognosis and promotes cell proliferation and invasion in cutaneous squamous cell carcinoma

  2018cites this paper
• miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer

  2017cites this paper
• Peritoneal carcinomatosis: limits of diagnosis and the case for liquid biopsy

  2017cites this paper
• MicroRNA-195 inhibits the proliferation and invasion of pancreatic cancer cells by targeting the fatty acid synthase/Wnt signaling pathway

  2017cites this paper